Vanguard Group Portfolio holdings
AUM
$6.18T
1-Year Return
25.19%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Quarter Return
+8.42%
1 Year Return
+25.19%
3 Year Return
+103.99%
5 Year Return
+190.29%
10 Year Return
+458.75%
AUM
$3.7T
AUM Growth
+$249B
(+7.2%)
Cap. Flow
+$35.4B
Cap. Flow
% of AUM
0.96%
Top 10 Holdings %
Top 10 Hldgs %
18.76%
Holding
4,384
New
180
Increased
3,235
Reduced
780
Closed
51
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$2.99B |
| 2 |
International Flavors & Fragrances
IFF
|
+$2.35B |
| 3 |
Coca-Cola
KO
|
+$1.42B |
| 4 |
Merck
MRK
|
+$1.29B |
| 5 |
ConocoPhillips
COP
|
+$1.28B |
Top Sells
| 1 |
Alibaba
BABA
|
+$13.3B |
| 2 |
Apple
AAPL
|
+$1.93B |
| 3 |
Walt Disney
DIS
|
+$1.85B |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$1.61B |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$1.23B |
Sector Composition
| 1 | Technology | 22.42% |
| 2 | Financials | 13.81% |
| 3 | Healthcare | 12.88% |
| 4 | Consumer Discretionary | 11.69% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Arbutus Biopharma
ABUS
$939M
| $9.43M | ﹤0.01% |
2,832,227
+84,468
| +3% | +$281K |
|
3177
Gold Resource Corp
GORO
$114M
| $9.42M | ﹤0.01% |
3,566,122
+32,156
| +0.9% | +$84.9K |
|
|
BRT
3178
BRT Apartments
BRT
$295M
| $9.41M | ﹤0.01% |
558,624
-66,568
| -11% | -$1.12M |
|
3179
AerCap
AER
$22.1B
| $9.39M | ﹤0.01% |
159,922
+12,121
| +8% | +$712K |
|
3180
Timberland Bancorp
TSBK
$285M
| $9.38M | ﹤0.01% |
337,100
+8,570
| +3% | +$238K |
|
3181
Outlook Therapeutics
OTLK
$48.4M
| $9.37M | ﹤0.01% |
208,264
+91,782
| +79% | +$4.13M |
|
|
PFBI
3182
DELISTED
Premier Financial Bancorp
PFBI
| $9.35M | ﹤0.01% |
502,699
+8,518
| +2% | +$158K |
|
3183
Taysha Gene Therapies
TSHA
$884M
| $9.34M | ﹤0.01% |
460,248
-4,602
| -1% | -$93.4K |
|
|
AFMD
3184
DELISTED
Affimed
AFMD
| $9.31M | ﹤0.01% |
117,656
+49,469
| +73% | +$3.91M |
|
3185
First Bank
FRBA
$421M
| $9.3M | ﹤0.01% |
763,810
-208,686
| -21% | -$2.54M |
|
|
MARK
3186
DELISTED
Remark Holdings, Inc.
MARK
| $9.29M | ﹤0.01% |
407,505
+16,122
| +4% | +$368K |
|
|
NOVN
3187
DELISTED
Novan, Inc. Common Stock
NOVN
| $9.28M | ﹤0.01% |
594,530
-100,999
| -15% | -$1.58M |
|
|
TLMD
3188
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
| $9.27M | ﹤0.01% |
1,472,911
| – | – |
|
3189
Vanguard Mega Cap 300 Index ETF
MGC
$7.84B
| $9.26M | ﹤0.01% |
66,005
+3,437
| +5% | +$482K |
|
|
TYME
3190
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $9.24M | ﹤0.01% |
5,189,007
+2,573,379
| +98% | +$4.58M |
|
3191
Assembly Biosciences
ASMB
$173M
| $9.23M | ﹤0.01% |
167,198
+4,726
| +3% | +$261K |
|
|
VIA
3192
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $9.22M | ﹤0.01% |
172,691
+20,130
| +13% | +$1.07M |
|
3193
EyePoint Pharmaceuticals
EYPT
$919M
| $9.19M | ﹤0.01% |
904,439
+582,736
| +181% | +$5.92M |
|
|
GFN
3194
DELISTED
General Finance Corporation
GFN
| $9.18M | ﹤0.01% |
755,878
+4,548
| +0.6% | +$55.3K |
|
3195
Parke Bancorp
PKBK
$268M
| $9.17M | ﹤0.01% |
458,629
+5,117
| +1% | +$102K |
|
3196
Preformed Line Products
PLPC
$978M
| $9.17M | ﹤0.01% |
133,346
+10,355
| +8% | +$712K |
|
|
CYBE
3197
DELISTED
Cyberoptics Corp
CYBE
| $9.16M | ﹤0.01% |
352,743
-33,148
| -9% | -$861K |
|
3198
Bankwell Financial Group
BWFG
$352M
| $9.15M | ﹤0.01% |
339,625
+9,234
| +3% | +$249K |
|
3199
Universal Technical Institute
UTI
$1.54B
| $9.13M | ﹤0.01% |
1,563,812
+98,130
| +7% | +$573K |
|
|
AGRX
3200
DELISTED
Agile Therapeutics, Inc
AGRX
| $9.11M | ﹤0.01% |
2,189
+3
| +0.1% | +$12.5K |
|